JSM vs RARE · P/E 16, $5.23B cap vs rev $350.0M
Navient Corporation SR NT 6% 121543 (JSM) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Navient Corporation SR NT 6% 121543 (JSM) is a other company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
JSM does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
JSM currently screens at market cap $5.23B and trailing P/E 15.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the JSM and RARE stock pages for the full models.
Not investment advice.